- 基本信息
|
导师姓名：
|
董柏君
|
学科代码：
|
100210
|
|
|
性别：
|
男
|
学科名称：
|
外科学
|
|
培养单位：
|
附属仁济医院
|
三级学科
|
泌尿外
|
|
导师类型：
|
硕士生导师
|
专业领域名称：
|
|
|
联系方式：
|
E-Mail: dongbaijun@renji.com
|
专业领域代码：
|
|
|
邮编：
|
200127
|
邮箱地址：
|
dongbaijun@renji.com
|
- 研究方向 (点击浏览详细信息)
- 社会任职
| |
|
上海市泌尿外科学会青年委员会副主任委员
|
|
中国抗癌协会肿瘤介入学专业委员会消融专家委员会委员
|
|
国际冷冻学会委员
|
|
中国医师协会泌尿外科分会青年委员
|
|
中华医学会泌尿外科分会青年委员
|
- 科研项目
| YG2017MS47 | 3D打印指导下的前列腺靶向冷冻消融 | 上海交通大学医工交叉面上项目 |
2018-01~2020-12
|
21万元
| 课题负责人 |
| 201640247 | 外周血游离DNA检测在转移性去势抵抗性前列腺癌靶向治疗预测预后中的应用 | 上海市卫计委 |
2017-01~2019-12
|
5万元
| 课题负责人 |
| 81672850 | HOXD13在去势抵抗性前列腺癌转移和神经内分泌分化中的作用 | 国家自然基金面上项目 |
2017-01~2020-12
|
58万元
| 课题负责人 |
| 15ZZ058 | 端粒失保护在前列腺癌进展转移中的作用和分子机制 | 上海市教委 |
2015-01~2017-12
|
8万元
| 课题负责人 |
- 学术论文
|
Fan L#, Wang R#, Chi C#, Cai W, Zhang Y, Qian H, Shao X, Wang Y, Xu F, Pan J, Zhu Y, Shangguan X, Zhou L,, Xue W*.
|
Systemic immune- inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration-resistant prostate cancer patients.
|
Prostate
|
2018
|
78(4):250-256.
|
|
Xin Z#, Zhang Y#, Jiang Z, Zhao L, Fan L, Wang Y, Xie S, Shangguan X, Zhu Y, Pan J, Liu Q, Huang Y,, Xue W*.
|
Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate.
|
Hum Pathol.
|
2018
|
S0046-8177(18)30182-5
|
|
Zheng H#, Cai A, Zhou Q, Xu P, Zhao L, Li C,, Gao H*.
|
Optimal preprocessing of serum and urine metabolomic data fusion for staging prostate cancer through design of experiment.
|
Anal Chim Acta.
|
2017
|
991:68-75.
|
|
Fan L#, Chi C#, Guo S#, Wang Y, Cai W, Shao X, Xu F, Pan J, Zhu Y, Shangguan X, Xin Z, Hu J, Qian H, Xie S, Wang R, Zhou L,, Xue W*.
|
Serum Pre-Albumin Predicts the Clinical Outcome in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone
|
J Cancer.
|
2017
|
8(17):3448-3455.
|
|
, Fan L#, Wang Y#, Chi C, Ma X, Wang R, Cai W, Shao X, Pan J, Zhu Y, Shangguan X, Xin Z, Hu J, Xie S, Kang X, Zhou L*, Xue W*.
|
Influence of abiraterone acetate on neuroendocrine differentiation in chemotherapy-naive metastatic castration-resistant prostate cancer.
|
Prostate
|
2017
|
77(13): 1373-1380.
|
|
Wang YQ#, Zhu YJ#, Pan JH, Xu F, Shao XG, Sha JJ, Liu Q, Huang YR,, Xue W*.
|
Peripheral monocyte count: an independent diagnostic and prognostic biomarker for prostate cancer - a large Chinese cohort study.
|
Asian J Androl.
|
2017
|
19(5):579-585.
|
|
Fan L#, Wang Y#, Chi C#, Pan J, Shangguan X, Xin Z, Hu J, Zhou L,, Xue W*.
|
Chromogranin A and neurone-specific enolase variations during the first three months of abiraterone therapy predict outcomes in patients with metastatic castration-resistant prostate cancer.
|
BJU Int.
|
2017
|
120(2):226-232.
|
|
Wang Y#, Xie S#, Shangguan X, Pan J, Zhu Y, Xin Z, Xu F, Shao X, Fan L, Sha J, Liu Q,, Xue W*.
|
Prostate transitional zone volume-based nomogram for predicting prostate cancer and high progression prostate cancer in a real-world population.
|
J Cancer Res Clin Oncol.
|
2017
|
143(7):1157-1166.
|
|
Wang Y#, Chen W#, Hu C#, Wen X#, Pan J, Xu F, Zhu Y, Shao X, Shangguan X, Fan L, Sha J, Wang Z, Cai Y, Liu Q,, Xue W*.
|
Albumin and Fibrinogen Combined Prognostic Grade Predicts Prognosis of Patients with Prostate Cancer.
|
J Cancer.
|
2017
|
8(19):3992-4001.
|
|
, Gao Y#, Kang X#, Gao H#, Zhang J, Guo H, You MJ, Xue W, Cheng J*, Huang Y*.
|
SENP1 promotes proliferation of clear cell renal cell carcinoma through activation of glycolysis.
|
Oncotarget.
|
2016
|
7(49):80435-80449.
|
|
Xu F#, Gao Y#, Wang Y#, Pan J#, Sha J, Shao X, Kang X, Qin J, James You M, Huang Y,, Xue W*.
|
Decreased TSPAN1 promotes prostate cancer progression and is a marker for early biochemical recurrence after radical prostatectomy.
|
Oncotarget.
|
2016
|
7(39):63294-63305.
|
|